Tin-based antitumour drugs /
While platinum compounds are already clinically used as anticancer agents, tin compounds exhibiting high enough antitumour activity have not yet entered the clinical phase. This situation seems paradoxical since 50% of the tested tin compounds show some activity, an unusually high percentage. Clinic...
| Corporate Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Conference Proceeding eBook |
| Language: | English |
| Published: |
Berlin ; New York :
Springer-Verlag,
[1990]
|
| Series: | NATO ASI series. Cell biology ;
vol. 37. |
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Internet
Connect to the full text of this electronic bookAvailable Online
| Call Number: |
RC271.O73 N37 1989 |
|
|---|---|---|
| Call Number | Status | Get It |
| RC271.O73 N37 1989 | Available | |